InspireMD (Nasdaq:NSPR) announced today that it appointed Dr. Peter A. Soukas as its new chief medical officer.
Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback